Medifast
MED
267 hedge funds and large institutions have $1.06B invested in Medifast in 2023 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 107 increasing their positions, 80 reducing their positions, and 47 closing their positions.
34% more repeat investments, than reductions
Existing positions increased: 107 | Existing positions reduced: 80
7.76% more ownership
Funds ownership: 86.02% → 93.78% (+7.8%)
1% more capital invested
Capital invested by funds: $1.05B → $1.06B (+$15.1M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 279 → 267 (-12)
15% less first-time investments, than exits
New positions opened: 40 | Existing positions closed: 47
45% less call options, than puts
Call options by funds: $9.77M | Put options by funds: $17.8M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$40.4M |
| 2 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$8.74M |
| 3 |
Voloridge Investment Management
Jupiter,
Florida
|
+$8.07M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$7.95M |
| 5 |
Morgan Stanley
New York
|
+$7.93M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$17.2M |
| 2 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
-$10.4M |
| 3 |
LOAMS
Lombard Odier Asset Management (Switzerland)
Petit-Lancy,
Switzerland
|
-$8.36M |
| 4 |
BlackRock
New York
|
-$6.21M |
| 5 |
TC
TwinBeech Capital
Purchase,
New York
|
-$3.77M |
MED Hedge Fund Activity: Q1 2023 in Review
267 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q1 2023, worth a combined $1.06B — up 1.4% from $1.05B a quarter earlier.
Sellers outnumbered buyers: 47 funds closed out of MED and 40 opened new positions — a net loss of 7 holders — while 80 trimmed existing stakes and 107 added.
The largest buyer was Millennium Management, adding an estimated $40.4M. The largest seller was Rice Hall James & Associates, cutting an estimated $17.2M.
- 267 institutional investors held Medifast (MED) as of Q1 2023, down from 279 in Q4 2022.
- Funds reported $1.06B of Medifast stock for Q1 2023, up 1.4% quarter-over-quarter.
- 40 funds opened new Medifast positions in Q1 2023 and 47 closed out, a net change of -7 holders.
- The largest Medifast buyer in Q1 2023 was Millennium Management, an estimated $40.4M added.
- The largest Medifast seller in Q1 2023 was Rice Hall James & Associates, an estimated $17.2M sold.
Based on aggregated 13F filings for Q1 2023.